Cargando…
Systematic assessment in an animal model of the angiogenic potential of different human cell sources for therapeutic revascularization
INTRODUCTION: Endothelial progenitor cells (EPC) capable of initiating or augmenting vascular growth were recently identified within the small population of CD34-expressing cells that circulate in human peripheral blood and which are considered hematopoietic progenitor cells (HPC). Soon thereafter h...
Autores principales: | Barclay, G Robin, Tura, Olga, Samuel, Kay, Hadoke, Patrick WF, Mills, Nicholas L, Newby, David E, Turner, Marc L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580461/ https://www.ncbi.nlm.nih.gov/pubmed/22759659 http://dx.doi.org/10.1186/scrt114 |
Ejemplares similares
-
Percutaneous coronary intervention causes a rapid but transient mobilisation of CD34(+)CD45(−) cells
por: Padfield, Gareth J, et al.
Publicado: (2014) -
Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources
por: Tura, Olga, et al.
Publicado: (2007) -
Optimal ex vivo expansion of neutrophils from PBSC CD34(+ )cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO
por: Tura, Olga, et al.
Publicado: (2007) -
Robust Revascularization in Models of Limb Ischemia Using a Clinically Translatable Human Stem Cell-Derived Endothelial Cell Product
por: MacAskill, Mark G., et al.
Publicado: (2018) -
Resistance Mechanisms of Anti-angiogenic Therapy and Exosomes-Mediated Revascularization in Cancer
por: Zeng, Ye, et al.
Publicado: (2020)